Clinical Trials Logo

Clinical Trial Summary

The decrease or absence sexual desire and arousal is the alteration of the sexual sphere that women most commonly refer to in adulthood and old age. Many women can refer a decrease or absence of desire and / or arousal without having the disorder typified in the DSM-5, but that can cause discomfort, worry and relationship problems in their day to day. Libicare® is a food supplement whose ingredients could have positive effects on the improvement of sexual function in women with low desire and arousal levels. The main ingredients of Libicare® are: - Trigonella Foenum-graecum (Trigonella) (1) - Tribulus Terrestris (Tribulus) (2) - Turnera Diffusa (Damiana) (3)


Clinical Trial Description

The main objective is to describe the effectivity of LIBICARE® in the improvement of desire and sexual arousal in women between 45 and 65 years old, in real life. The secondary objectives of the study are: - Evaluation of the 6 domains of the EVAS-M scale at 2 and 4 months of treatment. - Assessment of the safety of LIBICARE® by collecting serious and non-serious adverse events. - Evaluation of patient satisfaction with treatment at 2 and 4 months of treatment. - Therapeutic compliance in taking the food supplement at 2 and 4 months of treatment. - Study of the hormonal variation in relation to the values of total testosterone, free testosterone and SHBG, at the beginning, at 2 months and at 4 months of treatment, in those patients in which it is determined by routine clinical practice. - To evaluate the degree of usefulness of the EVAS-M scale in clinical practice after 4 months of treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04124640
Study type Observational
Source Procare Health Iberia S.L.
Contact
Status Completed
Phase
Start date October 29, 2019
Completion date November 15, 2021

See also
  Status Clinical Trial Phase
Completed NCT05806424 - Investigation of Awareness Levels of Women Living in Turkey About Kegel Exercises and Pelvic Floor Muscles
Completed NCT01364623 - PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women Phase 1
Recruiting NCT06060691 - the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction Phase 1
Recruiting NCT04419961 - Sexual Dysfunction and an Educational Program to Improve the Quality of Sexual Function in Vietnamese Pregnant Women in First Trimester N/A
Completed NCT04122703 - Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction N/A
Recruiting NCT03498443 - Effect of Pelvic Organ Prolapse Surgeries on Female Sexual Function in Egyptian Women
Completed NCT03232801 - A Mindfulness-based Intervention for Older Women With Low Sexual Desire N/A
Completed NCT00995072 - Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function N/A
Active, not recruiting NCT05168371 - Cognitive-Behavioural & Mindfulness-Based Online Programs for Female Sexual Dysfunction N/A
Recruiting NCT04384172 - Effect of Peripheral Neuromodulation on Vaginal Blood Flow N/A
Completed NCT03463707 - BP101 for Adults With Female Sexual Dysfunction Phase 3
Recruiting NCT01078077 - The Impact of a Topical Vasodilating Cream on Female Sexual Experience N/A
Not yet recruiting NCT06237166 - Evaluation of an Online Intervention for Female Sexual Dysfunction N/A
Completed NCT02229721 - Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women Phase 2
Completed NCT01724658 - Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women Phase 2
Completed NCT00479570 - Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction. Phase 2
Withdrawn NCT02862184 - Female Sexual Dysfunction, Risks and Outcomes (FSFI) N/A
Completed NCT01195701 - Clitoral Location in Relation to Sexual Function Using Pelvic Imaging N/A
Completed NCT04484753 - Validation of iPelvis App for Female Pelvic Floor Dysfunction N/A
Completed NCT03500146 - Sexual Function Trial of Overactive Bladder: Medication Versus PTNS